Download FREE Report Sample
Download Free sampleNext-Generation Breast Cancer Diagnostic and Screening Market contains market size and forecasts of Next-Generation Breast Cancer Diagnostic and Screening in Global, including the following market information:
Global Next-Generation Breast Cancer Diagnostic and Screening Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Next-Generation Breast Cancer Diagnostic and Screening market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Real-Time PCR (q-PCR) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Next-Generation Breast Cancer Diagnostic and Screening include Abbott Laboratories, Agendia, Agilent Technologies, Ambry Genetics, Biocept, Biotheranostics, Centogene, Danaher Corporation and EXACT Sciences Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Next-Generation Breast Cancer Diagnostic and Screening companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Next-Generation Breast Cancer Diagnostic and Screening Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Next-Generation Breast Cancer Diagnostic and Screening Market Segment Percentages, by Type, 2021 (%)
Real-Time PCR (q-PCR)
Immunohistochemistry (IHC)
Next-Generation Sequencing (NGS)
Fluorescent In-Situ Hybridization (FISH)
Global Next-Generation Breast Cancer Diagnostic and Screening Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Next-Generation Breast Cancer Diagnostic and Screening Market Segment Percentages, by Application, 2021 (%)
Hospital-associated Labs
Cancer Research Institutes
Diagnostic Centers
Global Next-Generation Breast Cancer Diagnostic and Screening Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Next-Generation Breast Cancer Diagnostic and Screening Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Next-Generation Breast Cancer Diagnostic and Screening revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Next-Generation Breast Cancer Diagnostic and Screening revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Agendia
Agilent Technologies
Ambry Genetics
Biocept
Biotheranostics
Centogene
Danaher Corporation
EXACT Sciences Corporation
Roche Holding AG
Fulgent Genetics
Illumina
Invitae
Lucence Diagnostics Pte Ltd
Myriad Genetics
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
